- patients with a previous history of allergic transfusion reaction. - lactating or pregnant women and a positive pregnancy test. - patients who have been treated with plasma in the 21 days prior to the screening / baseline visit. - patients who are at the time of study, participating in another clinical trial. - patients who haven't completed all study procedures.

- patients with a previous history of allergic transfusion reaction. - lactating or pregnant women and a positive pregnancy test. - patients who have been treated with plasma in the 21 days prior to the screening / baseline visit. - patients who are at the time of study, participating in another clinical trial. - patients who haven't completed all study procedures.